These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5665748)

  • 21. Clinical and laboratory double-blind investigation on effect of fibrinolytic therapy in patients with cutaneous vasculitis.
    Dodman B; Cunliffe WJ; Roberts BE; Sibbald R
    Br Med J; 1973 Apr; 2(5858):82-4. PubMed ID: 4573315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinolytic response of diabetics and non-diabetics to adrenaline.
    Tanser AR
    J Clin Pathol; 1967 May; 20(3):231-3. PubMed ID: 5602554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-enzymatic fibrinolytic agents].
    Nilsson IM; Hedner U
    Ann Anesthesiol Fr; 1978; 19(8):697-702. PubMed ID: 31113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of platelet adhesiveness by phenformin combined with ethylestrenol or stanozolol.
    Chakrabarti R
    Acta Univ Carol Med Monogr; 1972; 53():261-2. PubMed ID: 4670736
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter: Fibrinolysis and venous thrombosis.
    Fearnley GR
    Br Med J; 1975 Jan; 1(5951):208. PubMed ID: 1111752
    [No Abstract]   [Full Text] [Related]  

  • 26. Prospective study of a phenformin-like substance (moroxydine chloride) in patients with deficient vessel wall fibrinolysis.
    Tengborn L; Hedner U; Nilsson IM
    J Med; 1982; 13(5-6):353-64. PubMed ID: 6963328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Physiological and pharmacological aspects of fibrinolysis].
    Fearnley GR
    Clin Ter; 1971 May; 57(3):205-25. PubMed ID: 5110942
    [No Abstract]   [Full Text] [Related]  

  • 28. Fibrinolysis.
    Fearnley GR
    Adv Drug Res; 1973; 7():107-63. PubMed ID: 4280240
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma fibrinolytic system and blood pressure in patients with hypertensive cardiovascular disease treated with reserpine and phenformin.
    Worowski K; Prokopowicz J; Gabryelewicz A
    Haematologia (Budap); 1970; 4(3):399-403. PubMed ID: 4256949
    [No Abstract]   [Full Text] [Related]  

  • 30. Prophylaxis of recurrent venous thrombosis with long-term enhancement of fibrinolysis.
    Bielawiec M; Lukjan H; Myśliwiec M; Dabrowski S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):971-6. PubMed ID: 94894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of ethyloestrenol on fibrinolysis in the vessel wall.
    Hedner U; Nilsson IM; Isacson S
    Br Med J; 1976 Sep; 2(6038):729-31. PubMed ID: 974570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenformin and ethyloestrenol in recurrent deep venous thrombosis (DVT).
    Hedner U; Nilsson IM; Isacson S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):372-80. PubMed ID: 63424
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological fibrinolysis in occlusive vascular disease and its relation to diabetes mellitus.
    Fearnley GR
    Postgrad Med J; 1969 May; 45():52-62. PubMed ID: 5364315
    [No Abstract]   [Full Text] [Related]  

  • 34. Proceedings: Clinical and laboratory double-blind investigation on the effect of fibrinolytic therapy in patients with cutaneous vasculitis.
    Cunliffe WJ; Dodman B; Roberts BE
    Ann Rheum Dis; 1973 Nov; 32(6):591-2. PubMed ID: 4586510
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prophylaxis of thrombosis. Present-day conditions and new possibilities].
    Wysocki K
    Pol Arch Med Wewn; 1977 Aug; 58(2):175-82. PubMed ID: 905165
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of fenformin on the blastomogenic action of 1,2-dimethylhydrazine in rats].
    Anisimov VN; Pozharisskiĭ KM; Dil'man VM
    Vopr Onkol; 1980; 26(8):54-8. PubMed ID: 7415052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial: Fibrinolysis and venous thrombosis.
    Br Med J; 1974 Nov; 4(5941):365-6. PubMed ID: 4425884
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
    Bielawiec M; Bodzenta A; Lukjan H; Kiersnowska-Rogowska B; Kłoczko J; Myśliwiec M; Dabrowski S; Tymiński W; Czestochowska E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):223-9. PubMed ID: 2427405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinolytic enhancement by stanozolol: a double-blind trial.
    Davidson JF; McDonald GA; McNicol GP
    J Clin Pathol; 1972 Jul; 25(7):639. PubMed ID: 4560843
    [No Abstract]   [Full Text] [Related]  

  • 40. THE PHARMACOLOGICAL ENHANCEMENT OF BLOOD FIBRINOLYTIC ACTIVITY WITH SPECIAL REFERENCE TO PHENFORMIN.
    FEARNLEY GR; CHAKRABARTI R
    Acta Cardiol; 1964; 19():1-13. PubMed ID: 14133801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.